Extracts from Deutsches Ärzteblatt (Journal of the German Medical Association) Nov. 1932: Dr. Haedenkamp, executive director of the Hartmannbund (one of the two largest German medical associations); he is editor of its journal, Deutsches Ärzteblatt (DÄ) sent a petition to the ministry . . . Continue reading →
schizophrenia
Jay Katz, MD (1922–2008)
An eminent scholar, a professor of law and ethics at Yale Law School who spent more than 50 years tackling confounding questions on the boundaries between law, medicine, psychology and ethics. An inspirational teacher and mentor not only to his law students . . . Continue reading →
Loren Mosher, MD (1933–2004)
Loren Mosher, MD, a psychiatrist who espoused drug-free treatment for schizophrenia. He was a graduate of Stanford and Harvard Medical School. He served as the first chief of the Center for Studies of Schizophrenia of the National Institutes of Mental Health from . . . Continue reading →
John W. Thompson, MD (1906–1965)
John W. Thompson, MD “must be counted among the saints of his century and of medicine, a person who could confront horrors that others ignored and devote his life to rectifying them.” (Paul Weindling. John W. Thompson: Psychiatrist in the Shadow of . . . Continue reading →
Two NIMH Directors Debunk DSM & Deplore Psychiatry’s Unscientific Modus Operandi
The myth of the DSM “Bible” is debunked: “at best, [the DSM is] a dictionary, creating a set of labels and defining each. . . . Continue reading →
India’s Dark Underbelly: Clinical Trial Business
Besides these cases, 1,833 children from the Chacha Nehru Bal Chikitsalaya (the paediatric hospital affiliated with MGM Medical College) and 233 mentally ill patients had been enrolled in clinical trials without any consent, according to documents submitted to the Supreme Court.
Two UC Nueurosurgeons Banned From Human Research
Dr. J. Paul Muizelaar, Chairman of the department of neurological surgery, and Dr. Rudolph J. Schrot, injected bacteria into the head wounds of terminally ill patients, calling it "innovative treatment."
Unexamined Drug Epidemic–the Elephant No One Wants to See
“Prescription drug therapy stands as one of the most significant perils to health resulting from human activity.” What’s the FDA doing to stem the tide of this preventable epidemic? Continue reading →
Vicissitudes of Psychiatry’s Diagnostic Manual Revisions
The latest area of controversy focuses on the proposed revision of the definition "behavioral addiction disorder" extending the addiction diagnosis to include drug, alcohol and gambling. It is estimated that the change would expand the number of people labeled as "addicts" by 20 to 30 million who would be entitled to treatment and disability payments costing taxpayers many hundreds of millions of dollars. Continue reading →
Fraudulent Science: What’s Retracted, What’s Not
Even if retracted, published clinical trial reports that misrepresent findings, withhold negative data, or make false, or unsubstantiated claims have done irreparable damage. AHRP calls upon all medical journals to adopt a publication policy requiring submission of the sponsor’s formal Clinical Study Report to accompany articles about clinical trial findings.
Fraudulent Science: What’s Retracted, What Is Not
Even as the corruption of science is no longer a dirty little secret, but is in plain sight, no one is doing anything tostop it. April 16, 2012 A Sharp Rise in Retractions Prompts Calls for Reform By CARL ZIMMER In . . . Continue reading →
Confidential Expert Witness Report Documents Psychiatrists’ Corrupt Practices
"From the start, the [Tri-University Schizophrenia Practice Guidelines] project subverted scientific integrity, appearing to be a purely scientific venture when it was at its core, a marketing venture for Risperdal."